Trials / Unknown
UnknownNCT05077644
Mobile Application in the Management of Mild to Moderate Postpartum Depression (PPD)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 65 (estimated)
- Sponsor
- Curio Digital Therapeutics, Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Primary Objective: Evaluate the user experience with the Stella (TM) app for the management of Postpartum Depression in an observed population for 8 calendar weeks.
Detailed description
Women between 18 and 50 years of age who have had a live birth within 4 months prior to study start date and have a diagnosis of mild to moderate PPD. A total of 65 women residing in the state of New York, New Jersey and Connecticut will be recruited to participate in the study. Patient reported outcomes of mild to moderate depression (using EPDS) will be verified by a behavioral health therapist using the Hamilton Depression Rating Scale (HAM-D).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Stella (TM) Mobile Application | Treatment of mild-to-moderate postpartum depression (PPD) using Cognitive Behavioral Therapy techniques. |
Timeline
- Start date
- 2021-10-01
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2021-10-14
- Last updated
- 2021-10-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05077644. Inclusion in this directory is not an endorsement.